The Penn CFAR represents a collaboration among the University of Pennsylvania, The Children's Hospital of Philadelphia, and The Wistar Institute. This Center is committed to the principles laid out in the National CFAR Mission Statement and strives to create a highly interactive environment among faculty on campus engaged in HIV/AIDS research. The Administrative Core (Core A) conducts, coordinates, and monitors activities of the Center to build infrastructure that fosters interdisciplinary and translational research in HIV/AIDS by establishing shared resource Core facilities, educational activities, and a Developmental Grants program in basic, clinical, behavioral and social sciences. The Administrative Core is also deeply committed to initiatives that build strong ties to the campus and the community. The Administrative will continue to be directed by James Hoxie. Ronald Collman assumed the role as CFAR Co-Director as of November 1, 2007. when Francisco Gonzalez-Scarano stepped down to attend to his responsibilities as Chair of Neurology and Co-Director of the Penn Comprehensive Neurosciences Center. The Director's and Co-Director's leadership oversees a governing Executive Committee and four Scientific Programs: Virology/Pathogenesis (Director, Robert Doms and Co-Director, Guido Silvestri);Clinical/Therapeutics (Director, Ian Frank;and Co-Director, Pablo Tebas);Immunology/Vaccine (Director, David Weiner;and Co-Director, Terri Finkel);and Behavioral &Social Sciences (Director, David Metzger). The Administrative Core implements the overall mission of the CFAR in association with the Executive Committee and with assistance from an External Advisory Committee and an Internal Advisory Board. The Administrative Core provides the management and scientific direction for the CFAR and establishes the necessary linkages among participants from the Center's three institutions. The goals of this Core continue to be 1) to facilitate communication that fosters collaborations between CFAR members;2) to ensure that opportunities in emerging scientific areas and technologies in HIV/AIDS research are recognized and pursued;3) to ensure that shared Core facilities serve the research needs of participating members and comply with the policies by which they were established;4) to ensure sound fiscal management and accountability for CFAR Core activities and Developmental funds;5) to establish multidisciplinary educational programs for faculty and students;and 6) to work with the Behavioral &Social Sciences (F) and International (I) Cores to develop strong outreach programs that address the needs of domestic and international populations most affected by the HIV epidemic.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI045008-13
Application #
8293242
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
13
Fiscal Year
2011
Total Cost
$335,587
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Papasavvas, Emmanouil; Lada, Steven M; Joseph, Jocelin et al. (2018) Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV. AIDS :
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187
Bengsch, Bertram; Ohtani, Takuya; Khan, Omar et al. (2018) Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells. Immunity 48:1029-1045.e5
Brocca-Cofano, Egidio; Xu, Cuiling; Wetzel, Katherine S et al. (2018) Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques. J Virol 92:
Costea, Paul I; Hildebrand, Falk; Arumugam, Manimozhiyan et al. (2018) Enterotypes in the landscape of gut microbial community composition. Nat Microbiol 3:8-16
Page, Kathleen R; Grieb, Suzanne Dolwick; Nieves-Lugo, Karen et al. (2018) Enhanced immigration enforcement in the USA and the transnational continuity of HIV care for Latin American immigrants in deportation proceedings. Lancet HIV 5:e597-e604
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
Opondo, Philip R; Ho-Foster, Ari R; Ayugi, James et al. (2018) HIV Prevalence Among Hospitalized Patients at the Main Psychiatric Referral Hospital in Botswana. AIDS Behav 22:1503-1516
Venuto, Charles S; Lim, Jihoon; Messing, Susan et al. (2018) Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 23:345-351
Clarke, Erik L; Lauder, Abigail P; Hofstaedter, Casey E et al. (2018) Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low-Microbial Content Samples. Am J Respir Crit Care Med 197:225-234

Showing the most recent 10 out of 775 publications